Lysosomal Acid Lipase Deficiency Treatment Market Industry Overview 2034
The Lysosomal Acid Lipase Deficiency (LAL-D) Treatment Market is gaining momentum as awareness of rare genetic disorders increases and advancements in biotechnology accelerate the development of targeted therapies. LAL-D is a rare, inherited metabolic disease characterized by the accumulation of cholesterol esters and triglycerides in multiple organs, primarily affecting the liver, spleen, and...
0 Комментарии 0 Поделились 9 Просмотры 0 предпросмотр